GBI Biomanufacturing
June 24, 2026
Theater 3
Type: Company Presentation
Focus Area:
Contract Manufacturing Organization
GBI, formerly Goodwin Biotechnology, Inc., is a full-service CDMO for large molecule drug substance and drug product, as well as HCT/Ps. GBI's leading advantage is our Single-Source Solution™ which means that clients can partner with us from early-stage development through commercial launch for multi-modality biologics including complex bioconjugates. Our state-of-the-art 2K L Single-Use facility is based in South Florida. Over the last 30 years GBI has supported more than 450 client programs and 50+ regulatory filings.
Company HQ City:
Plantation
Company HQ State:
Florida
Company HQ Country:
United States
Year Founded:
1992
Lead Product in Development:
NA
CEO
Karl Pinto
Chairman of the Board
Development Phase of Lead Product
Other/Not Applicable
Number of Unlicensed Products Looking for Licensing
NA
When you expect your next catalyst update?
NA
What is your next catalyst (value inflection) update?
NA
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}